Authors/Disclosures
|
Samuel Goldlust, MD
(John Theruer Cancer Center)
|
No disclosure on file |
|
Robert Cavaliere, MD
(Baptist MD Anderson)
|
No disclosure on file |
|
Mackenzie A. Michell-Robinson, MSc
|
Mackenzie A. Michell-Robinson has nothing to disclose. |
|
Alexandros L. Georgiadis, MD
(MCALLEN MEDICAL CENTER)
|
No disclosure on file |
|
Antonio M. Omuro, MD, FAAN
(Stanford University)
|
Dr. Omuro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ono Therapeutics. Dr. Omuro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Telix. Dr. Omuro has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Curevac. The institution of Dr. Omuro has received research support from NIH. The institution of Dr. Omuro has received research support from Arcus Biosciences. The institution of Dr. Omuro has received research support from Denovo Biopharma. The institution of Dr. Omuro has received research support from Ono Pharmaceutical. The institution of Dr. Omuro has received research support from Servier. The institution of Dr. Omuro has received research support from Nanopharmaceuticals. The institution of Dr. Omuro has received research support from Denovo. |
|
Lisa M. DeAngelis, MD, FAAN
|
Dr. DeAngelis has received publishing royalties from a publication relating to health care. |
|
Lauren E. Abrey, MD
|
No disclosure on file |
|
Herbert B. Newton, MD
(U Hospitals of Cleveland)
|
No disclosure on file |
|
|
No disclosure on file |
|
Andrew B. Lassman, MD, FAAN
(Columbia University Irving Medical Center)
|
No disclosure on file |